Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabaletta in Oculopharyngeal Muscular Dystrophy
NCT02015481Phase 2Completed
- Sponsor
- Bioblast Pharma Ltd.
- Start
- Feb 2014
- Primary completion
- Apr 2016
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of trehalose in oculopharyngeal muscular dystrophy (OPMD), sponsored by Bioblast Pharma Ltd.. Started Feb 2014; status: completed.
02
Drugs
trehalose
03
Conditions
oculopharyngeal muscular dystrophy (OPMD)
Beyond the preview
Go deeper on NCT02015481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015481.